Skip Nav Destination
A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation
Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia
Integrative prognostic risk score in acute myeloid leukemia with normal karyotype
The role of vanin-1 and oxidative stress–related pathways in distinguishing acute and chronic pediatric ITP
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases
Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium
Issue Archive
April 28 2011
In this Issue
Table of Contents
Inside Blood
Plenary Paper
PLENARY PAPER
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
Jana Jakubikova,Sophia Adamia,Maria Kost-Alimova,Steffen Klippel,David Cervi,John F. Daley,Dana Cholujova,Sun-Young Kong,Merav Leiba,Simona Blotta,Melissa Ooi,Jake Delmore,Jacob Laubach,Paul G. Richardson,Jan Sedlak,Kenneth C. Anderson,Constantine S. Mitsiades
Perspectives
Review Article
Clinical Trials and Observations
A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation
CME
André Tichelli,Hubert Schrezenmeier,Gérard Socié,Judith Marsh,Andrea Bacigalupo,Ulrich Dührsen,Anke Franzke,Michael Hallek,Eckhard Thiel,Martin Wilhelm,Britta Höchsmann,Alain Barrois,Kim Champion,Jakob R. Passweg
Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia
Clinical Trials & Observations
Claire Oudin,Marie-Claude Simeoni,Nicolas Sirvent,Audrey Contet,Audrey Begu-Le Coroller,Pierre Bordigoni,Catherine Curtillet,Maryline Poirée,Isabelle Thuret,Barbara Play,Mara Carazza Massot,Pascal Chastagner,Hervé Chambost,Pascal Auquier,Gérard Michel
Integrative prognostic risk score in acute myeloid leukemia with normal karyotype
Clinical Trials & Observations
Frederik Damm,Michael Heuser,Michael Morgan,Katharina Wagner,Kerstin Görlich,Anika Großhennig,Iyas Hamwi,Felicitas Thol,Ewa Surdziel,Walter Fiedler,Michael Lübbert,Lothar Kanz,Christoph Reuter,Gerhard Heil,Ruud Delwel,Bob Löwenberg,Peter J. M. Valk,Jürgen Krauter,Arnold Ganser
Hematopoiesis and Stem Cells
Immunobiology
Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function
Isabelle Dunand-Sauthier,Marie-Laure Santiago-Raber,Leonardo Capponi,Charles E. Vejnar,Olivier Schaad,Magali Irla,Queralt Seguín-Estévez,Patrick Descombes,Evgeny M. Zdobnov,Hans Acha-Orbea,Walter Reith
Lymphoid Neoplasia
Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies
Waleed Alduaij,Andrei Ivanov,Jamie Honeychurch,Eleanor J. Cheadle,Sandeep Potluri,Sean H. Lim,Kazuyuki Shimada,Claude H. T. Chan,Alison Tutt,Stephen A. Beers,Martin J. Glennie,Mark S. Cragg,Tim M. Illidge
Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
Lapo Alinari,Bo Yu,Beth A. Christian,Fengting Yan,Jungook Shin,Rosa Lapalombella,Erin Hertlein,Mark E. Lustberg,Carl Quinion,Xiaoli Zhang,Gerard Lozanski,Natarajan Muthusamy,Mette Prætorius-Ibba,Owen A. O'Connor,David M. Goldenberg,John C. Byrd,Kristie A. Blum,Robert A. Baiocchi
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma
Paul A. Moore,Wenjun Zhang,G. Jonah Rainey,Steve Burke,Hua Li,Ling Huang,Sergey Gorlatov,Maria Concetta Veri,Sudeepta Aggarwal,Yinhua Yang,Kalpana Shah,Linda Jin,Sunan Zhang,Leilei He,Tengfei Zhang,Valentina Ciccarone,Scott Koenig,Ezio Bonvini,Syd Johnson
Myeloid Neoplasia
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
Qing Zhou,Meghan E. Munger,Rachelle G. Veenstra,Brenda J. Weigel,Mitsuomi Hirashima,David H. Munn,William J. Murphy,Miyuki Azuma,Ana C. Anderson,Vijay K. Kuchroo,Bruce R. Blazar
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies
Ramon V. Tiu,Lukasz P. Gondek,Christine L. O'Keefe,Paul Elson,Jungwon Huh,Azim Mohamedali,Austin Kulasekararaj,Anjali S. Advani,Ronald Paquette,Alan F. List,Mikkael A. Sekeres,Michael A. McDevitt,Ghulam J. Mufti,Jaroslaw P. Maciejewski
Phagocytes, Granulocytes, and Myelopoiesis
Platelets and Thrombopoiesis
The role of vanin-1 and oxidative stress–related pathways in distinguishing acute and chronic pediatric ITP
Clinical Trials & Observations
Bing Zhang,Clara Lo,Lei Shen,Ruchira Sood,Carol Jones,Kristina Cusmano-Ozog,Shaun Park-Snyder,Wendy Wong,Michael Jeng,Tina Cowan,Edgar G. Engleman,James L. Zehnder
Red Cells, Iron, and Erythropoiesis
Thrombosis and Hemostasis
Transfusion Medicine
Transplantation
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases
Clinical Trials & Observations
Ansgar S. Schulz,Gerhard Glatting,Manfred Hoenig,Catharina Schuetz,Susanne A. Gatz,Simon Grewendorf,Monika Sparber-Sauer,Rainer Muche,Norbert Blumstein,Gabriele Kropshofer,Meinolf Suttorp,Donald Bunjes,Klaus-Michael Debatin,Sven N. Reske,Wilhelm Friedrich
Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium
Clinical Trials & Observations
Joseph Pidala,Brenda Kurland,Xiaoyu Chai,Navneet Majhail,Daniel J. Weisdorf,Steven Pavletic,Corey Cutler,David Jacobsohn,Jeanne Palmer,Sally Arai,Madan Jagasia,Stephanie J. Lee
Vascular Biology
Other Departments
-
Cover Image
Cover Image
CD20 and CD74 labeling by specific fluorescent antibodies. Binding of CD20 and CD74 in mantle cell lymphoma cells was examined by laser-scanning confocal microscopy. Cells were incubated with rhodamine-conjugated rituximab (red) and Alexa Fluor 488-conjugated milatuzumab (green) in the presence of a cross-linking antibody, for 2 hours at 37°C. DRAQ5 was used for nuclear staining (blue). Cross-linked milatuzumab forms large aggregates and colocalizes with cross-linked rituximab on the surface of mantle cell lymphoma cells. See the article by Alinari et al on page 4530.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals